Generics will continue to dominate Central and Eastern European pharma markets until 2011

Article | 30 November 2009

The pharmaceutical market in Central and Eastern Europe is dominated by generic drugs, with this subdivision worth 17.2 billion euros ($25.5 billion) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Merck

Merck KGaA

Aventis

Aventis Pharma

Novartis

Go to company listing